Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats

Synapse

Volumn 63, Issue 1, 2009, Pages 15-21

  Kayir, Hakan ^a   Goktalay, Gokhan ^a,b   Yildirim, Murat ^a   Uzbay, Tayfun I ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Clozapine; Locomotor sensitization; Nicotine; Rat(s); Substance dependence

Indexed keywords

CLOZAPINE; NICOTINE;

ADAPTATION; ADDICTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CIGARETTE SMOKING; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; TOBACCO DEPENDENCE;

ANIMALS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; MOTOR ACTIVITY; NEURAL INHIBITION; NICOTINE; RATS; RATS, WISTAR;

EID: 58149479870     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20576     Document Type: Article

References (49)

1. Addy N, Levin ED. 2002. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology 27:534-541.
2. Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. 2000. Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice. J Psychopharmacol 14:353-359.
3. Albanese MJ, Khantzian EJ, Murphy SL, Green AI. 1994. Decreased substance use in chronically psychotic patients treated with clozapine. Am J Psychiatry 151:780-781.
4. Ashby CR, Jr, Wang RY. 1996. Pharmacological actions of the atypical antipsychotic drug clozapine: A review. Synapse 24:349-394.
5. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM. 1993. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117-124.
6. Batel P. 2000. Addiction and schizophrenia. Eur Psychiatry 15:115-122.
7. Brioni JD, Kim DJ, O'Neill AB, Williams JE, Decker MW. 1994. Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res 643:1-9.
8. Buckley PF. 1998. Substance abuse in schizophrenia: A review. J Clin Psychiatry 59(Suppl 3):26-30.
9. Celik E, Uzbay IT, Karakas S. 2006. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice. Prog Neuropsychopharmacol Biol Psychiatry 30:50-55.
10. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D. 2004. Dopamine and drug addiction: The nucleus accumbens shell connection. Neuro-pharmacology 47(Suppl 1):227-241.
11. Drake RE, Xie H, McHugo GJ, Green AL. 2000. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 26:441-449.
12. Faghih R, Gfesser GA, Gopalakrishnan M. 2007. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Recent Patents CNS Drug Discov 2:99-106.
13. Filip M, Papla I, Nowak E, Przegalinski E. 2003. Blocking impact of clozapine on cocaine locomotor and sensitizing effects in rats. Polym J Pharmacol 55:1125-1130.
14. Glassman AH. 1993. Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry 150:546-553.
15. Harris J, Kongs S, Aliens worth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R. 2004. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29:1378-1385.
16. Iba MM, Fung J, Pak YW, Thomas PE, Fisher H, Sekowski A, Hal-laday AK, Wagner GC. 1999. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metab Dispos 27:977-982.
17. Kameda G, Dadmarz M, Vogel WH. 2000. Influence of various drugs on the voluntary intake of nicotine by rats. Neuropsychobiology 41:205-209.
18. Kempsill FE, Pratt JA. 2000. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine. Br J Pharmacol. 131:997-1003.
19. Kosten TA, Nestler EJ. 1994. Clozapine attenuates cocaine conditioned place preference. Life Sci 55:PL9-PL14.
20. Levin ED, Rezvani AH. 2007. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem Pharmacol 74:1182-1191.
21. Levin ED, McClernon FJ, Rezvani AH. 2006. Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization.Psychopharmacology 184:523-539.
22. Leyton M. 2007. Conditioned and sensitized responses to stimulant drugs in humans. Prog Neuropsychopharmacol Biol Psychiatry 31:1601-1613.
23. Mansvelder HD, McGehee DS. 2002. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53:606-617.
24. Mansvelder HD, De Rover M, McGehee DS, Brussaard AB. 2003. Cholinergic modulation of dopaminergic reward areas: Upstream and downstream targets of nicotine addiction. Eur J Pharmacol. 480:117-123.
25. Marshall DL, Redfern PH, Wonnacott S. 1997. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519.
26. Martin LF, Kem WR, Freedman R. 2004. Alpha-7 nicotinic receptor agonists: Potential new candidates for the treatment of schizophrenia. Psychopharmacology 174:54-64.
27. McEvoy J, Freudenreich O, McGee M, Vanderzwaag C, Levin E, Rose J. 1995. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 37:550-552.
28. Miller DK, Harrod SB, Green TA, Wong MY, Bardo MT, Dwoskin LP. 2003. Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats. Pharmacol Biochem Behav 74:279-286.
29. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. 2005. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79-104.
30. Nestler EJ. 2005. Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449.
31. Olincy A, Stevens KE. 2007. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol. 74:1192-1201.
32. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
33. Prior TI, Chue PS, Tibbo P, Baker GB. 1999. Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol 9:301-309.
34. Procyshyn RM, Ihsan N, Thompson D. 2001. A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics. Int Clin Psychopharmacol 16:291-294.
35. Procyshyn RM, Tse G, Sin O, Flynn S. 2002. Concomitant clozapine reduces smoking in patients treated with risperidone. Eur Neuro-psychopharmacol 12:77-80.
36. Rezvani AH, Kholdebarin E, Dawson E, Levin ED. 2008. Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. Int J Neuropsycho-pharmacol 11:63-70.
37. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
38. Robinson TE, Berridge KC. 2001. Incentive-sensitization and addiction. Addiction 96:103-114.
39. San L, Arranz B, Martinez-Raga J. 2007. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders. Eur Addict Res 13:230-243.
40. Schwieler L, Engberg G, Erhardt S. 2004. Clozapine modulates mid-brain dopamine neuron firing via interaction with the NMDA receptor complex. Synapse 52:114-122.
41. Seeman P, Van Tol HH. 1994. Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270.
42. Semenova S, Markou A. 2003. Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Biol Psychiatry 54:1249-1264.
43. Shim I, Javaid JI, Wirtshafter D, Jang SY, Shin KH, Lee HJ, Chung YC, Chun BG. 2001. Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behav Brain Res 121:137-147.
44. Shim I, Kim HT, Kim YH, Chun BG, Hahm DH, Lee EH, Kim SE, Lee HJ. 2002. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Eur J Pharmacol. 443:119-124.
45. Shoaib M, Benwell ME, Akbar MT, Stolerman IP, Balfour DJ. 1994. Behavioural and neurochemical adaptations to nicotine in rats: Influence of NMDA antagonists. Br J Pharmacol 111:1073-1080.
46. Singhal SK, Zhang L, Morales M, Oz M. 2007. Antipsychotic clozapine inhibits the function of a7-nicotinic acetylcholine receptors. Neuropharmacology 52:387-394.
47. Stewart J, Badiani A. 1993. Tolerance and sensitization to the behavioral effects of drugs. Behavioral Pharmacology 4:289-312.
48. Ulusu U, Uzbay IT, Kayir H, Alici T, Karakas S. 2005. Evidence for the role of nitric oxide in nicotine-induced locomotor sensitization in mice. Psychopharmacology 178:500-504.
49. Wei C, Caccavale RJ, Weyand EH, Chen S, Iba MM. 2002. Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung. Cancer Lett 8;178:25-36.